Ahmann A, Chow F, Vivian F, et al
"The actual price to the consumer for all of these drugs has come down a lot in the last year," Forman said
In the trials of these drug classes, tirzepatide (the SURMOUNT program) produced average weight loss roughly in the 15% to 21% range across doses at about 72 weeks, while semaglutide (the STEP program) produced around 15% at about 68 weeks
Anyone who experiences a suspected side effect from any medicine including those received within a clinical trial is encouraged to report it via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk or via the Yellow Card app
If youve adopted a healthy diet and made lifestyle changes yet still find yourself far from your ideal weight, trying Tirzepatide might be the next step toward achieving your weight loss objectives
It is frequently searched alongside Retatrutide, Semaglutide and other incretin compounds